| Product Code: ETC10599813 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Human Hormone Drugs Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Human Hormone Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 China Human Hormone Drugs Market - Industry Life Cycle |
3.4 China Human Hormone Drugs Market - Porter's Five Forces |
3.5 China Human Hormone Drugs Market Revenues & Volume Share, By Hormone Type, 2021 & 2031F |
3.6 China Human Hormone Drugs Market Revenues & Volume Share, By Delivery Form, 2021 & 2031F |
3.7 China Human Hormone Drugs Market Revenues & Volume Share, By Drug Category, 2021 & 2031F |
3.8 China Human Hormone Drugs Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.9 China Human Hormone Drugs Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
4 China Human Hormone Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hormone-related disorders in China |
4.2.2 Growing awareness about the benefits of hormone therapy |
4.2.3 Technological advancements in drug delivery systems for human hormone drugs |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for human hormone drugs in China |
4.3.2 High cost associated with human hormone drugs |
4.3.3 Potential side effects and health risks associated with hormone therapy |
5 China Human Hormone Drugs Market Trends |
6 China Human Hormone Drugs Market, By Types |
6.1 China Human Hormone Drugs Market, By Hormone Type |
6.1.1 Overview and Analysis |
6.1.2 China Human Hormone Drugs Market Revenues & Volume, By Hormone Type, 2021 - 2031F |
6.1.3 China Human Hormone Drugs Market Revenues & Volume, By Insulin, 2021 - 2031F |
6.1.4 China Human Hormone Drugs Market Revenues & Volume, By Growth Hormones, 2021 - 2031F |
6.1.5 China Human Hormone Drugs Market Revenues & Volume, By Thyroid Hormones, 2021 - 2031F |
6.1.6 China Human Hormone Drugs Market Revenues & Volume, By Estrogens, 2021 - 2031F |
6.1.7 China Human Hormone Drugs Market Revenues & Volume, By Androgens, 2021 - 2031F |
6.2 China Human Hormone Drugs Market, By Delivery Form |
6.2.1 Overview and Analysis |
6.2.2 China Human Hormone Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.2.3 China Human Hormone Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.4 China Human Hormone Drugs Market Revenues & Volume, By Oral/Injectable, 2021 - 2031F |
6.2.5 China Human Hormone Drugs Market Revenues & Volume, By Transdermal, 2021 - 2031F |
6.2.6 China Human Hormone Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3 China Human Hormone Drugs Market, By Drug Category |
6.3.1 Overview and Analysis |
6.3.2 China Human Hormone Drugs Market Revenues & Volume, By Prescription-based, 2021 - 2031F |
6.3.3 China Human Hormone Drugs Market Revenues & Volume, By Over-the-counter, 2021 - 2031F |
6.3.4 China Human Hormone Drugs Market Revenues & Volume, By Prescription-based, 2021 - 2031F |
6.3.5 China Human Hormone Drugs Market Revenues & Volume, By Prescription-based, 2021 - 2031F |
6.3.6 China Human Hormone Drugs Market Revenues & Volume, By Prescription-based, 2021 - 2031F |
6.4 China Human Hormone Drugs Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 China Human Hormone Drugs Market Revenues & Volume, By Diabetes, 2021 - 2031F |
6.4.3 China Human Hormone Drugs Market Revenues & Volume, By Pediatric Growth, 2021 - 2031F |
6.4.4 China Human Hormone Drugs Market Revenues & Volume, By Hypothyroidism, 2021 - 2031F |
6.4.5 China Human Hormone Drugs Market Revenues & Volume, By Menopause, 2021 - 2031F |
6.4.6 China Human Hormone Drugs Market Revenues & Volume, By Hypogonadism, 2021 - 2031F |
6.5 China Human Hormone Drugs Market, By Treatment Type |
6.5.1 Overview and Analysis |
6.5.2 China Human Hormone Drugs Market Revenues & Volume, By Long-acting, 2021 - 2031F |
6.5.3 China Human Hormone Drugs Market Revenues & Volume, By Short-acting, 2021 - 2031F |
6.5.4 China Human Hormone Drugs Market Revenues & Volume, By Combination, 2021 - 2031F |
6.5.5 China Human Hormone Drugs Market Revenues & Volume, By Hormone Replacement, 2021 - 2031F |
6.5.6 China Human Hormone Drugs Market Revenues & Volume, By Long-acting, 2021 - 2031F |
7 China Human Hormone Drugs Market Import-Export Trade Statistics |
7.1 China Human Hormone Drugs Market Export to Major Countries |
7.2 China Human Hormone Drugs Market Imports from Major Countries |
8 China Human Hormone Drugs Market Key Performance Indicators |
8.1 Number of clinical trials conducted for human hormone drugs in China |
8.2 Adoption rate of new drug delivery systems for human hormone drugs |
8.3 Rate of patient adherence to hormone therapy regimens |
9 China Human Hormone Drugs Market - Opportunity Assessment |
9.1 China Human Hormone Drugs Market Opportunity Assessment, By Hormone Type, 2021 & 2031F |
9.2 China Human Hormone Drugs Market Opportunity Assessment, By Delivery Form, 2021 & 2031F |
9.3 China Human Hormone Drugs Market Opportunity Assessment, By Drug Category, 2021 & 2031F |
9.4 China Human Hormone Drugs Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.5 China Human Hormone Drugs Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10 China Human Hormone Drugs Market - Competitive Landscape |
10.1 China Human Hormone Drugs Market Revenue Share, By Companies, 2024 |
10.2 China Human Hormone Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here